216 related articles for article (PubMed ID: 25908301)
61. Phenylephrine activates eNOS Ser 1177 phosphorylation and nitric oxide signaling in renal hypertensive rat aorta.
Silva BR; Pernomian L; Grando MD; Bendhack LM
Eur J Pharmacol; 2014 Sep; 738():192-9. PubMed ID: 24886887
[TBL] [Abstract][Full Text] [Related]
62. Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia.
Zhang W; Iliff JJ; Campbell CJ; Wang RK; Hurn PD; Alkayed NJ
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1475-81. PubMed ID: 19471280
[TBL] [Abstract][Full Text] [Related]
63. Soluble epoxide hydrolase deletion attenuated nicotine-induced arterial stiffness via limiting the loss of SIRT1.
Hu S; Luo J; Fu M; Luo L; Cai Y; Li W; Li Y; Dong R; Yang Y; Tu L; Xu X
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H353-H368. PubMed ID: 34142887
[TBL] [Abstract][Full Text] [Related]
64. Epoxides and soluble epoxide hydrolase in cardiovascular physiology.
Imig JD
Physiol Rev; 2012 Jan; 92(1):101-30. PubMed ID: 22298653
[TBL] [Abstract][Full Text] [Related]
65. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
66. [Soluble epoxide hydrolase and lipid metabolism].
Ma XX; Liu Y; Zhu Y
Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):267-71. PubMed ID: 21416942
[TBL] [Abstract][Full Text] [Related]
67. Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase.
Bianco RA; Agassandian K; Cassell MD; Spector AA; Sigmund CD
Brain Res; 2009 Sep; 1291():60-72. PubMed ID: 19643090
[TBL] [Abstract][Full Text] [Related]
68. Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.
Roche C; Guerrot D; Harouki N; Duflot T; Besnier M; Rémy-Jouet I; Renet S; Dumesnil A; Lejeune A; Morisseau C; Richard V; Bellien J
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():148-54. PubMed ID: 26022136
[TBL] [Abstract][Full Text] [Related]
69. ANTIHYPERTENSIVE AND CARDIOPROTECTIVE EFFECTS OF EPOXYEICOSATRIENOIC ACID ANALOGS AND SOLUBLE EPOXIDE HYDROLASE INHIBITORS (REVIEW).
Papiashvili N; Gongadze N; Bakuridze A; Bakuridze K
Georgian Med News; 2021 Mar; (312):125-132. PubMed ID: 33964840
[TBL] [Abstract][Full Text] [Related]
70. Targeting epoxides for organ damage in hypertension.
Imig JD
J Cardiovasc Pharmacol; 2010 Oct; 56(4):329-35. PubMed ID: 20531214
[TBL] [Abstract][Full Text] [Related]
71. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
[TBL] [Abstract][Full Text] [Related]
72. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
[TBL] [Abstract][Full Text] [Related]
73. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
[TBL] [Abstract][Full Text] [Related]
74. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
75. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
76. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
77. Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth.
Oguro A; Sakamoto K; Suzuki S; Imaoka S
Biol Pharm Bull; 2009 Dec; 32(12):1962-7. PubMed ID: 19952412
[TBL] [Abstract][Full Text] [Related]
78. Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen.
Huang A; Sun D
Front Pharmacol; 2018; 9():1222. PubMed ID: 30420806
[TBL] [Abstract][Full Text] [Related]
79. Ephx2-gene deletion affects acetylcholine-induced relaxation in angiotensin-II infused mice: role of nitric oxide and CYP-epoxygenases.
Hanif A; Edin ML; Zeldin DC; Nayeem MA
Mol Cell Biochem; 2020 Feb; 465(1-2):37-51. PubMed ID: 31797255
[TBL] [Abstract][Full Text] [Related]
80. Cytochrome P450 eicosanoids and cerebral vascular function.
Imig JD; Simpkins AN; Renic M; Harder DR
Expert Rev Mol Med; 2011 Mar; 13():e7. PubMed ID: 21356152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
